Device Trial Radar · NCT05657392
Quantitative EEG Changes Following Repetitive Transcranial Magnetic Stimulation in Patients With Post Stroke (EEG-rTMS)
Last checked: Nov 19, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Apr 15, 2021
Primary completion
Oct 15, 2023
Study completion Apr 15, 2024
Sponsor
- Lead sponsor
- Izmir Katip Celebi UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- First posted
- Dec 20, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Quantitative EEG (qEEG) has been used as an effective tool in the diagnosis and prognosis of brain-related diseases. In the literature, a variety of qEEG parameters have been proven informative in the prognosis of stroke. In addition, it has been demonstrated that changes in certain qEEG parameters during traditional/task-specific rehabilitation approaches are correlated with clinical outcomes of functional motor recovery. Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a non-invasive and therapeutic treatment used to accelerate and enhance the recovery process of motor function in stroke patients. Many studies have reported that inhibiting contralesional rTMS may have positive effects in stroke patients with severe upper extremity motor impairment. In this context, the aim of the proposed study is to investigate whether there is a correlation between the change in qEEG parameters and the improvement of motor functions associated with rTMS treatment and to provide an electrophysiological prognostic biomarker of inhibiting contralesional rTMS for stroke patients.
Conditions
- Stroke
- Stroke, Ischemic
- Stroke/Brain Attack
Interventions
repetitive Transcranial Magnetic Stimulation (rTMS)Device
Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive intervention that uses magnetic fields to stimulate nerve cells to improve the symptoms of a variety of disorders, including stroke-related motor impairment. Last few decades, it has been revealed that rTMS accelerates motor recovery and may reduce stroke-related symptoms.
32 electrode electroencephalography (EEG)Other
32-electrode EEG will be non-invasively recorded from electrodes placed in a montage over the scalp while the participant is resting
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in The Fugl-Meyer Assessment (FMA)Time frame: (1) Baseline, (2) At the end of the last session of the intervention (immediately after the 10th session, each session is 1 day)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Izmir Katip Celebi University
Izmir, Cigli, Turkey (Türkiye) · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.